Bryan Giraudo Insider Profile

18 Followers
Bryan Giraudo, Director at Protagonist Therapeutics, holds 480.01K shares in Gossamer Bio (Ticker: GOSS), holds 18.00K shares in Protagonist Therapeutics (Ticker: PTGX). Most recently, Bryan Giraudo Bought ― shares of Gossamer Bio on Jun 20, 2024 for an estimated value of 59.00K.
tipranks
Bryan Giraudo

Bryan Giraudo
Protagonist Therapeutics (PTGX)
Director

Ranked #3,497 out of 99,335 Corporate Insiders

Profitable Transactions

53%
8 out of 15 Profitable Transactions

Average Return

+30.50%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$1M
67.02%
32.98%
A breakdown of Bryan Giraudo's holdings

Insider Roles

Protagonist Therapeutics
(PTGX)
Director
Gossamer Bio
(GOSS)
COO/CFO
Roles that Bryan Giraudo holds in companies

Most Profitable Insider Trade

Stock:
Protagonist Therapeutics
(PTGX)
Rating:Informative Buy
Date:Dec 03, 2019 - Dec 03, 2020
Return:+354.10%
The most profitable trade made by Bryan Giraudo

Bryan Giraudo's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Protagonist Therapeutics
Dec 03, 2019
Director
Informative Buy
45.60K
$837.00K
Gossamer Bio
Jun 20, 2024
COO/CFO
Informative Buy
59.00K
$411.85K
List of latest transactions for each holding click on a transaction to see Bryan Giraudo's performance on stock

Bryan Giraudo insider profile FAQ

What is the percentage of profitable transactions made by Bryan Giraudo?
The percentage of profitable transactions made by Bryan Giraudo is 53%.
    What is the average return per transaction made by Bryan Giraudo?
    The average return per transaction made by Bryan Giraudo is 30.50%.
      What stocks does Bryan Giraudo hold?
      Bryan Giraudo holds: PTGX, GOSS stocks.
        What was Bryan Giraudo’s latest transaction?
        Bryan Giraudo latest transaction was an Informative Buy of $59.00K.
          What was Bryan Giraudo's most profitable transaction?
          Bryan Giraudo’s most profitable transaction was an Informative Buy of PTGX stock on December 3, 2019. The return on the trade was 354.10%.
            What is Bryan Giraudo's role in Protagonist Therapeutics?
            Bryan Giraudo's role in Protagonist Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.